Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
7,516
+6
+0.1% +$1.51K 1.4% 23
2026
Q1
$1.82M Hold
7,510
1.24% 26
2025
Q4
$2.22M Hold
7,510
1.61% 22
2025
Q3
$2.12M Hold
7,510
1.69% 20
2025
Q2
$2.21M Sell
7,510
-1,475
-16% -$380K 1.78% 19
2025
Q1
$2.23M Hold
8,985
1.66% 21
2024
Q4
$1.98M Hold
8,985
1.62% 19
2024
Q3
$1.99M Sell
8,985
-45
-0.5% -$8.82K 0.8% 26
2024
Q2
$1.56M Hold
9,030
1.16% 26
2024
Q1
$1.72M Sell
9,030
-85
-0.9% -$15.5K 1.28% 24
2023
Q4
$1.49M Buy
9,115
+377
+4% +$57K 1.31% 22
2023
Q3
$1.23M Hold
8,738
1.07% 25
2023
Q2
$1.17M Sell
8,738
-14
-0.2% -$1.81K 0.85% 25
2023
Q1
$1.15M Hold
8,752
0.95% 24
2022
Q4
$1.23M Buy
+8,752
New +$1.21M 0.79% 26

Other funds holding IBM

Slocum, Gordon & Co's IBM Position: Q2 2026 in Review

Slocum, Gordon & Co increased its IBM (IBM) stake by 0.08% in Q2 2026, buying an estimated $1.51K and bringing the position to 7,516 shares worth $2.11M. The position accounts for 1.4% of the portfolio, ranked #23.

Slocum, Gordon & Co first reported a position in IBM in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.23M in Q1 2025. 1,487 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Slocum, Gordon & Co held 7,516 shares of IBM worth $2.11M as of Q2 2026.
  • Slocum, Gordon & Co bought 6 IBM shares in Q2 2026, an estimated $1.51K.
  • IBM made up 1.4% of Slocum, Gordon & Co's portfolio in Q2 2026, its #23 holding.
  • Slocum, Gordon & Co first reported a position in IBM in Q4 2022 and has held it in 15 quarters since.
  • Slocum, Gordon & Co's IBM position peaked at $2.23M in Q1 2025.
  • 1,487 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.